These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18397322)

  • 1. Activity of soluble OX40 ligand is enhanced by oligomerization and cell surface immobilization.
    Müller N; Wyzgol A; Münkel S; Pfizenmaier K; Wajant H
    FEBS J; 2008 May; 275(9):2296-304. PubMed ID: 18397322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of rat OX40 ligand by molecular cloning.
    Akiba H; Atsuta M; Yagita H; Okumura K
    Biochem Biophys Res Commun; 1998 Oct; 251(1):131-6. PubMed ID: 9790919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.
    Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y
    Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of OX40-OX40 ligand interactions in langerhans cell function: enhanced contact hypersensitivity responses in OX40L-transgenic mice.
    Sato T; Ishii N; Murata K; Kikuchi K; Nakagawa S; Ndhlovu LC; Sugamura K
    Eur J Immunol; 2002 Nov; 32(11):3326-35. PubMed ID: 12555678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice.
    van Wanrooij EJ; van Puijvelde GH; de Vos P; Yagita H; van Berkel TJ; Kuiper J
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):204-10. PubMed ID: 17068285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimer stabilization, oligomerization, and antibody-mediated cell surface immobilization improve the activity of soluble trimers of CD27L, CD40L, 41BBL, and glucocorticoid-induced TNF receptor ligand.
    Wyzgol A; Müller N; Fick A; Munkel S; Grigoleit GU; Pfizenmaier K; Wajant H
    J Immunol; 2009 Aug; 183(3):1851-61. PubMed ID: 19596991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40 and OX40 ligand are differentially regulated on asthmatic airway smooth muscle.
    Krimmer DI; Loseli M; Hughes JM; Oliver BG; Moir LM; Hunt NH; Black JL; Burgess JK
    Allergy; 2009 Jul; 64(7):1074-82. PubMed ID: 19220210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid induction of OX40 ligand on primary T cells activated under DNA-damaging conditions.
    Kondo K; Okuma K; Tanaka R; Matsuzaki G; Ansari AA; Tanaka Y
    Hum Immunol; 2008 Sep; 69(9):533-42. PubMed ID: 18718855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo activities of OX40 (CD134)-IgG fusion protein isoforms with different levels of immune-effector functions.
    Taylor L; Bachler M; Duncan I; Keen S; Fallon R; Mair C; McDonald TT; Schwarz H
    J Leukoc Biol; 2002 Sep; 72(3):522-9. PubMed ID: 12223520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The crystal structure of the costimulatory OX40-OX40L complex.
    Compaan DM; Hymowitz SG
    Structure; 2006 Aug; 14(8):1321-30. PubMed ID: 16905106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
    Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
    Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction of OX40 ligand into lymphoma cells elicits anti-lymphoma immunity in vivo.
    Kaneko H; Hori T; Yanagita S; Kadowaki N; Uchiyama T
    Exp Hematol; 2005 Mar; 33(3):336-43. PubMed ID: 15730857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OX40 (CD134) and OX40 ligand interaction plays an adjuvant role during in vivo Th2 responses.
    Ishii N; Ndhlovu LC; Murata K; Sato T; Kamanaka M; Sugamura K
    Eur J Immunol; 2003 Sep; 33(9):2372-81. PubMed ID: 12938213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and function of the OX40/OX40L costimulatory pair during herpes stromal keratitis.
    Lepisto AJ; Xu M; Yagita H; Weinberg AD; Hendricks RL
    J Leukoc Biol; 2007 Mar; 81(3):766-74. PubMed ID: 17185358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical implications of increased OX40 ligand expression in patients with acute coronary syndrome.
    Liu DM; Yan JC; Wang CP; Chen GH; Ding S; Liu PJ; Du RZ
    Clin Chim Acta; 2008 Nov; 397(1-2):22-6. PubMed ID: 18674525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OX40 ligand shuts down IL-10-producing regulatory T cells.
    Ito T; Wang YH; Duramad O; Hanabuchi S; Perng OA; Gilliet M; Qin FX; Liu YJ
    Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13138-43. PubMed ID: 16924108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel antibody-4-1BBL fusion protein for targeted costimulation in cancer immunotherapy.
    Müller D; Frey K; Kontermann RE
    J Immunother; 2008 Oct; 31(8):714-22. PubMed ID: 18779748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel agonist anti-human OX40L monoclonal antibody that stimulates T cell proliferation and enhances cytokine secretion.
    Wang Q; Chen Y; Xie F; Ge Y; Wang X; Zhang X
    Hybridoma (Larchmt); 2009 Aug; 28(4):269-76. PubMed ID: 19663699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of FcεRI-dependent mast cell response by OX40L.
    Sibilano R; Pucillo C; Frossi B
    Methods Mol Biol; 2014; 1155():23-30. PubMed ID: 24788170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OX40-OX40 ligand interaction may activate phospholipase C signal transduction pathway in human umbilical vein endothelial cells.
    Yan J; Wang C; Du R; Liu P; Chen G
    Chem Biol Interact; 2009 Aug; 180(3):460-4. PubMed ID: 19416722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.